ADC Therapeutics SA (ADCT)
NYSE: ADCT · IEX Real-Time Price · USD
4.100
+0.010 (0.24%)
May 17, 2024, 4:00 PM EDT - Market closed
ADC Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ADC Therapeutics stock have an average target of 7.00, with a low estimate of 5.00 and a high estimate of 8.00. The average target predicts an increase of 70.73% from the current stock price of 4.10.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ADCT stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 3 | 3 | 3 | 3 |
Sell | 1 | 1 | 1 | 1 | 1 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 6 | 7 | 7 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +95.12% | May 7, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +119.51% | Apr 15, 2024 |
Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Apr 5, 2024 |
Guggenheim | Guggenheim | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +168.29% | Mar 28, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $8 | Buy | Reiterates | $8 | +95.12% | Mar 14, 2024 |
Financial Forecast
Revenue This Year
82.31M
from 69.56M
Increased by 18.34%
Revenue Next Year
93.68M
from 82.31M
Increased by 13.81%
EPS This Year
-2.19
from -2.94
EPS Next Year
-1.85
from -2.19
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 91.4M | 106.7M | 167.5M | 236.5M | 374.6M |
Avg | 82.3M | 93.7M | 150.2M | 211.1M | 306.6M |
Low | 73.1M | 74.4M | 130.2M | 173.0M | 263.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 31.3% | 29.6% | 78.8% | 57.5% | 77.5% |
Avg | 18.3% | 13.8% | 60.3% | 40.5% | 45.3% |
Low | 5.1% | -9.6% | 39.0% | 15.2% | 24.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.81 | -1.59 | -1.08 |
Avg | -2.19 | -1.85 | -1.38 |
Low | -2.61 | -2.16 | -1.81 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.